Nonprofit Wins FDA Approval for Tuberculosis Drug

20:00 EDT 14 Aug 2019 | BioSpace

TB Alliance became the first nonprofit organization to win regulatory approval from the U.S. Food and Drug Administration for a new drug aimed at treating some of the most drug-resistant forms of tuberculosis.

Original Article: Nonprofit Wins FDA Approval for Tuberculosis Drug


More From BioPortfolio on "Nonprofit Wins FDA Approval for Tuberculosis Drug"

Quick Search

Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...